News Focus
News Focus
Followers 60
Posts 11407
Boards Moderated 0
Alias Born 01/31/2008

Re: Steady_T post# 495202

Monday, 07/28/2025 11:50:44 AM

Monday, July 28, 2025 11:50:44 AM

Post# of 518823

Anavex is applying for one of the five slots for the new very rapid approval program.



When the purpose of the program is to show rapid progess of new drugs, and the FDA will want to showcase any approvals, seems like you would pick the company who:
1. Already did a filing for the drug so it has all its ducks lined up to go.
2. Has a drug with a large, critical unmet need like alz.
3. Is super safe, so you don't end up approving s drug that kills people and leads to criticism of the program.

AVXL 273 fits all the criteria.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News